GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (FRA:2BO) » Definitions » Net Change in Cash

Serina Therapeutics (FRA:2BO) Net Change in Cash : €-3.59 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Serina Therapeutics's Net Change in Cash for the three months ended in Dec. 2024 was €0.42 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was €-3.59 Mil.

Serina Therapeutics Net Change in Cash Historical Data

The historical data trend for Serina Therapeutics's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Net Change in Cash Chart

Serina Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Net Change in Cash
-0.31 0.21 6.50 -3.77

Serina Therapeutics Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 1.05 -2.45 -2.60 0.42

Serina Therapeutics Net Change in Cash Calculation

Serina Therapeutics's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-16.366+-0.021+12.617+0
=-3.77

Serina Therapeutics's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-4.382+-0.005+4.805+0
=0.42

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Serina Therapeutics Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Serina Therapeutics's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Serina Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (FRA:2BO) » Definitions » Net Change in Cash
Comparable Companies
FBRX ADAP STTK CTMX KRON GANX MGX ALVR ALGS DTIL VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
SER:USA
Address
601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806
Website
https://www.serinatherapeutics.com
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Serina Therapeutics Headlines

No Headlines